Categoria: Articoli in lingua originale

A child’s blood pressure, body mass index, blood glucose level and other laboratory tests and simple office measures may predict the risk of developing type 2 diabetes nine and 26 years later, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the

The incidence of type 1 diabetes in Northern Italy has been increasing in both children and young adults, researchers concluded after assessing the trends in incidence rates for 1984 to 2004.  The study identified a total of 1,773 incident cases of type 1 diabetes, with the average annual increases in

New findings by UT Southwestern researchers suggest that a drug already used to treat autoimmune disorders might also help slow the destruction of insulin-producing cells in patients recently diagnosed with insulin-dependent (type 1) diabetes. In type 1 diabetes, formerly known as juvenile diabetes, cells in the pancreas called beta cells,

Do emotions influence how diabetics manage their illness? That’s one of the questions doctoral psychology student Amy Janzen hopes she’ll get answered in a study she’s doing under the supervision of Dr. Heather Hadjistavropoulos at the University of Regina. “The goal of my research is to try and figure out

Adding insulin to standard diabetes drugs results in better blood sugar control for many with type 2 diabetes, British researchers report, and the dose and timing of insulin received can make a big difference. Specifically, a once-a-day, long-acting dose of insulin may be the best approach for patients making the

A meta-analysis of clinical data published today in Diabetologia, the medical journal for the European Association for the Study of Diabetes (EASD), demonstrated that the Novo Nordisk long-acting insulin Levemir® (insulin detemir [rDNA origin] injection) was not associated with any increase in the incidence of cancer when compared to human

The International Diabetes Federation : (IDF) released new data today showing that a staggering 285 million people worldwide have diabetes. The latest figures from the IDF Diabetes Atlas : indicate that people in low and middle-income countries (LMCs) are bearing the brunt of the epidemic, and that the disease is

Novo Nordisk’s Levemir was not associated in any increase in incidence of cancer when compared with human insulin in studies including some 9,000 patients, according to a new analysis released on Thursday. The Danish drugmaker has distanced itself from a scare over diabetes treatment Lantus, pointing out its modern insulin

A review of clinical studies presented at the European Association for the Study of Diabetes (EASD) meeting was not able to provide a definitive answer to questions over the safety of sanofi-aventis’ insulin product Lantus (insulin glargine). Researchers said that more work is needed to understand whether the use of

Sanofi-aventis has launched a major research programme designed to generate more information on whether there is any association between cancer and insulin use and to assess if there is any difference in risk between insulin glargine and other insulins. The research will contribute to the scientific resolution of the debate